BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7776910)

  • 1. Isolation of HIV-1 from experimentally contaminated multidose local anaesthetic vials.
    Druce JD; Locarnini SA; Birch CJ
    Med J Aust; 1995 May; 162(10):513-5. PubMed ID: 7776910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of HIV-1 from experimentally contaminated multidose local anaesthetic vials.
    Collignon PJ
    Med J Aust; 1995 Sep; 163(6):333-4. PubMed ID: 7565247
    [No Abstract]   [Full Text] [Related]  

  • 3. Isolation of HIV-1 from experimentally contaminated multidose local anaesthetic vials.
    Davis AR
    Med J Aust; 1995 Jul; 163(1):56. PubMed ID: 7609700
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolation of HIV-1 from experimentally contaminated multidose local anaesthetic vials.
    Byrne JJ
    Med J Aust; 1995 Jul; 163(1):53, 56. PubMed ID: 7609698
    [No Abstract]   [Full Text] [Related]  

  • 5. Iatrogenic contamination of multidose vials in simulated use. A reassessment of current patient injection technique.
    Plott RT; Wagner RF; Tyring SK
    Arch Dermatol; 1990 Nov; 126(11):1441-4. PubMed ID: 2173497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C Contamination of Medication Vials Accessed with Sterile Needles and Syringes.
    van Vlymen JM; Magnus J; Jaeger M; Breton S; Taylor NG; Phelan R; Sagan SM
    Anesthesiology; 2019 Aug; 131(2):305-314. PubMed ID: 31166244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-based estimates of the risk of human immunodeficiency virus and hepatitis B virus transmission through unsafe injections.
    Aylward B; Kane M; McNair-Scott R; Hu DJ; Hu DH
    Int J Epidemiol; 1995 Apr; 24(2):446-52. PubMed ID: 7635609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safe use of disposable syringes in anesthesia: cost effective or costly?
    Monti EJ
    CRNA; 1995 May; 6(2):86-90. PubMed ID: 7633348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the number of HIV transmissions through reused syringes and needles in the Mbeya Region, Tanzania.
    Hoelscher M; Riedner G; Hemed Y; Wagner HU; Korte R; von Sonnenburg F
    AIDS; 1994 Nov; 8(11):1609-15. PubMed ID: 7848599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidose vial contamination in anesthesia.
    Arrington ME; Gabbert KC; Mazgaj PW; Wolf MT
    AANA J; 1990 Dec; 58(6):462-6. PubMed ID: 2275319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of varying concentrations of bleach on in vitro HIV-1 replication and the relevance to injection drug use.
    Contoreggi C; Jones S; Simpson P; Lange WR; Meyer WA
    Intervirology; 2000; 43(1):1-5. PubMed ID: 10773730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaesthetic drugs and bacterial contamination.
    Magee L; Godsiff L; Matthews I; Farrington M; Park GR
    Eur J Anaesthesiol Suppl; 1995 Nov; 12():41-3. PubMed ID: 8719669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovering Infectious HIV from Novel Syringe-Needle Combinations with Low Dead Space Volumes.
    Abdala N; Patel A; Heimer R
    AIDS Res Hum Retroviruses; 2016; 32(10-11):947-954. PubMed ID: 27548374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report.
    Shah SM; Shapshak P; Rivers JE; Stewart RV; Weatherby NL; Xin KQ; Page JB; Chitwood DD; Mash DC; Vlahov D; McCoy CB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Mar; 11(3):301-6. PubMed ID: 8603266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial contamination of growth hormone solution and injection equipment during use by growth hormone deficient children.
    Zweens MJ; Drayer NM; Dankert J
    J Hosp Infect; 1991 Jun; 18(2):123-30. PubMed ID: 1678757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple withdrawals from single-use vials: a study on sterility.
    Ripoll Gallardo A; Meneghetti G; Ragazzoni L; Kroumova V; Ferrante D; Ingrassia PL; Ruzza P; Dell'Era A; Boniolo E; Koraqe G; Faggiano F; Della Corte F
    Int J Pharm; 2015 May; 485(1-2):160-3. PubMed ID: 25769293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume.
    Binka M; Paintsil E; Patel A; Lindenbach BD; Heimer R
    PLoS One; 2015; 10(11):e0139737. PubMed ID: 26536599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach.
    Shapshak P; McCoy CB; Shah SM; Page JB; Rivers JE; Weatherby NL; Chitwood DD; Mash DC
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):754-9. PubMed ID: 8207659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of the hazards of multiple use of disposable syringes and needles in intensified insulin therapy.
    Chlup R; Marsálek E; Bruns W
    Diabet Med; 1990 Aug; 7(7):624-7. PubMed ID: 2146071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to the human immunodeficiency virus in needles and syringes used by intravenous drug abusers.
    Wodak A; Dolan K; Imrie AA; Gold J; Wolk J; Whyte BM; Cooper DA
    Med J Aust; 1987 Sep; 147(6):275-6. PubMed ID: 3650679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.